JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

A Case Report of Uterine Müllerian Adenosarcoma With Sarcomatous Overgrowth

  • 0Medical Oncology, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.
Cureus +

|

February 7, 2024

|

February 7, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Uterine adenosarcoma is an aggressive cancer with poor prognosis. Multimodal treatment, including surgery, chemotherapy, and radiotherapy, offers local control but limited survival benefits for this rare tumor.

Area Of Science

  • Gynecologic Oncology
  • Surgical Pathology

Background

  • Uterine adenosarcoma is a rare and aggressive gynecologic malignancy.
  • It is characterized by a high risk of local and distant recurrence.
  • Current treatment modalities offer limited impact on overall survival.

Observation

  • A case of stage IIIB uterine adenosarcoma in a 79-year-old patient presenting with postmenopausal metrorrhagia is described.
  • Diagnosis was confirmed through immunohistochemistry.
  • The patient's initial presentation was postmenopausal bleeding.

Findings

  • Multimodal treatment involving surgery, chemotherapy, and radiotherapy was administered.
  • The treatment aimed for local disease control.
  • Despite interventions, overall survival remains a challenge.

Implications

  • This case highlights the aggressive nature of uterine adenosarcoma.
  • Multidisciplinary consultation is crucial for managing complex gynecologic cancers.
  • Further research into novel therapeutic strategies is warranted to improve outcomes for uterine adenosarcoma patients.

Keywords: